PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM)

Kurz, S; Silverman, JS; Hochman, T; Nayak, L; Arrillaga-Romany, I; Lee, E; Patel, A; Delara, M; Hsu, F; Imtiaz, T; Magnelli, L; Taylor, J; Cloughesy, T; Sulman, E; Golfinos, J; Zagzag, D; Snuderl, M; Goldberg, JD; Chi, AS

NEURO-ONCOLOGY, 2019; 21 (): 9